1. Home
  2. SBR vs AMPH Comparison

SBR vs AMPH Comparison

Compare SBR & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sabine Royalty Trust

SBR

Sabine Royalty Trust

HOLD

Current Price

$74.02

Market Cap

1.0B

Sector

Energy

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$19.05

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBR
AMPH
Founded
1982
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
SBR
AMPH
Price
$74.02
$19.05
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$30.29
AVG Volume (30 Days)
30.7K
581.3K
Earning Date
02-27-2026
05-06-2026
Dividend Yield
6.60%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.03
Revenue
N/A
$719,887,000.00
Revenue This Year
N/A
$7.34
Revenue Next Year
N/A
$4.81
P/E Ratio
$12.77
$9.36
Revenue Growth
N/A
N/A
52 Week Low
$58.25
$17.03
52 Week High
$84.39
$31.26

Technical Indicators

Market Signals
Indicator
SBR
AMPH
Relative Strength Index (RSI) 54.96 32.55
Support Level $65.77 N/A
Resistance Level $79.86 $28.56
Average True Range (ATR) 1.83 1.09
MACD 0.12 -0.09
Stochastic Oscillator 51.86 32.08

Price Performance

Historical Comparison
SBR
AMPH

About SBR Sabine Royalty Trust

Sabine Royalty Trust is an express trust which is formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: